Stay updated on MB-102 vs Fluorescein in Ocular Angiography Safety/Feasibility Clinical Trial
Sign up to get notified when there's something new on the MB-102 vs Fluorescein in Ocular Angiography Safety/Feasibility Clinical Trial page.

Latest updates to the MB-102 vs Fluorescein in Ocular Angiography Safety/Feasibility Clinical Trial page
- Check7 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.3%
- Check14 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference6%
- Check21 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference1.0%
- Check28 days agoNo Change Detected
- Check43 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.3%
- Check57 days agoChange DetectedThe web page has updated its version from v2.14.4 to v2.15.0, indicating a revision in the content. The phrase 'Here’s how you know' has been modified, suggesting a change in the presentation or explanation of information.SummaryDifference1.0%
- Check65 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to February 21, 2025.SummaryDifference1.0%
Stay in the know with updates to MB-102 vs Fluorescein in Ocular Angiography Safety/Feasibility Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MB-102 vs Fluorescein in Ocular Angiography Safety/Feasibility Clinical Trial page.